AU3312900A - Formulations for treatment of pain comprising vitamin b12 and phenylanine - Google Patents
Formulations for treatment of pain comprising vitamin b12 and phenylanineInfo
- Publication number
- AU3312900A AU3312900A AU33129/00A AU3312900A AU3312900A AU 3312900 A AU3312900 A AU 3312900A AU 33129/00 A AU33129/00 A AU 33129/00A AU 3312900 A AU3312900 A AU 3312900A AU 3312900 A AU3312900 A AU 3312900A
- Authority
- AU
- Australia
- Prior art keywords
- phenylanine
- vitamin
- pain
- formulations
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9906808 | 1999-03-24 | ||
GBGB9906808.2A GB9906808D0 (en) | 1999-03-24 | 1999-03-24 | Formulation for treatment of pain |
PCT/GB2000/001092 WO2000056404A1 (en) | 1999-03-24 | 2000-03-23 | Formulations for treatment of pain comprising vitamin b12 and phenylanine |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3312900A true AU3312900A (en) | 2000-10-09 |
Family
ID=10850289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU33129/00A Withdrawn AU3312900A (en) | 1999-03-24 | 2000-03-23 | Formulations for treatment of pain comprising vitamin b12 and phenylanine |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3312900A (en) |
GB (1) | GB9906808D0 (en) |
WO (1) | WO2000056404A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7232805B2 (en) | 2003-09-10 | 2007-06-19 | Inflabloc Pharmaceuticals, Inc. | Cobalamin conjugates for anti-tumor therapy |
JP5161472B2 (en) * | 2007-03-30 | 2013-03-13 | 小林製薬株式会社 | Analgesic composition |
JP5241127B2 (en) * | 2007-03-30 | 2013-07-17 | 小林製薬株式会社 | Analgesic composition |
EP2561879A1 (en) * | 2011-08-23 | 2013-02-27 | Protea Biopharma N.V. | Macrophage activating factor for use in the treatment of chronic fatigue syndrome (CFS) and CFS-related diseases and disorders |
JP7071754B2 (en) * | 2020-07-28 | 2022-05-19 | 株式会社東洋新薬 | Joint function improving composition |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4331145A (en) * | 1981-01-28 | 1982-05-25 | Arthur Winter | Multiple sclerosis treatment |
GB2286528B (en) * | 1994-02-17 | 1998-09-16 | Robert John Woodward | Dietary supplement |
EP0784476B1 (en) * | 1994-10-05 | 2002-11-06 | Cari Loder | Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and optionally a vitamin b 12 compound |
US6335323B2 (en) * | 1996-07-05 | 2002-01-01 | The Wwk Trust | Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin B12 and/or precursors or inducers of a neurotransmitter |
GB9617990D0 (en) * | 1996-08-29 | 1996-10-09 | Scotia Holdings Plc | Treatment of pain |
EP0835660A1 (en) * | 1996-10-14 | 1998-04-15 | Gaston Edmond Filomena Merckx | Products containing methylcobalamin for the treatment of multiple sclerosis or other demyelinating conditions |
DE19720818A1 (en) * | 1996-11-15 | 1998-05-20 | Sportmedizin Team Muenchen Arz | Composition enhancing sports performance |
-
1999
- 1999-03-24 GB GBGB9906808.2A patent/GB9906808D0/en active Pending
-
2000
- 2000-03-23 WO PCT/GB2000/001092 patent/WO2000056404A1/en not_active Application Discontinuation
- 2000-03-23 AU AU33129/00A patent/AU3312900A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000056404B1 (en) | 2000-12-21 |
GB9906808D0 (en) | 1999-05-19 |
WO2000056404A1 (en) | 2000-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
AU7842500A (en) | System for orthopedic treatment | |
AU2197100A (en) | Treatment of tooth surfaces and substance therefor | |
IL211081A0 (en) | Methods and devices for providing prolonged drug therapy | |
AU3784999A (en) | Methods for treatment of pain | |
AU3896900A (en) | Treatment of pain | |
HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them | |
AU8015398A (en) | Pharmaceutical formulations containing colostrum and the use of colostrum for the treatment of affections of the oral cavity | |
AU7106300A (en) | Treatment of skin disorders | |
IL142581A0 (en) | Method of providing cosmetic/medical therapy | |
AU3312900A (en) | Formulations for treatment of pain comprising vitamin b12 and phenylanine | |
AU5842300A (en) | Pharmaceutical composition useful for the treatment of tinnitus and hearing loss | |
AU4841799A (en) | Methods and pharmaceutical formulations for preventing and treating motion sickness | |
AU3760900A (en) | Treatment of menstrual function | |
AU2420101A (en) | Method and composition for the treatment of pain | |
AU2566201A (en) | Compounds and methods for the treatment of pain | |
AU2509801A (en) | Method for the cosmetic treatment of human skin | |
AU4053700A (en) | Enhanced tissue and subcellular delivery of vitamin e compounds | |
AU1405001A (en) | Treatment of diseases | |
IL150202A0 (en) | Method and composition for the treatment of pain | |
AU2683500A (en) | Compositions for the treatment of pain | |
AU2420201A (en) | Compounds and methods for the treatment of pain | |
AU1350099A (en) | Formulations for topical treatment of skin infections | |
IL150208A0 (en) | Compound and method for the treatment of pain | |
AU1392601A (en) | Prevention and treatment of biomaterial-associated infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK13 | Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant |